Go to Advanced Search

Showing results

110 of 216
HarrietKulgerMD.jpg
  • Embargo expired:
    8-Nov-2018 4:00 PM EST

Article ID: 703627

Yale Cancer Center scientists show immunotherapy drug can help patients with metastatic melanoma

Yale Cancer Center

When melanoma turns metastatic, it spreads to the brain in more than 40% of patients. Published today in the Journal of Clinical Oncology (JCO), a study by Yale Cancer Center researchers show a checkpoint inhibitor immunotherapy drug has meaningful benefit for these patients.

Released:
8-Nov-2018 11:05 AM EST
DanielBoffaMD.jpg

Article ID: 703518

Yale Cancer Center Finds Patients Choose Cancer Care Based on Hospital Affiliations

Yale Cancer Center

Branding matters when it comes to choosing a hospital, according to a new novel study by Yale Cancer Center (YCC) researchers published in the journal Annals of Surgical Oncology.

Released:
7-Nov-2018 9:30 AM EST
NickolaiPodoltsevMDPhD.jpg

Article ID: 703425

Yale Cancer Center investigators show recommended, but underused treatment for rare blood cancer saves lives

Yale Cancer Center

U.S. and European guidelines on treating Polycythemia Vera (PV), a potentially deadly blood cancer, call for two treatments for patients with high-risk disease: therapeutic phlebotomy and cytoreductive therapy with a drug called hydroxyurea (HU). HU is the most commonly used option, but evidence for HU treatment is limited and both treatments are underused. Now, researchers at Yale Cancer Center have documented reduced risk of death and incidence of blood clots in patients receiving those therapies.

Released:
5-Nov-2018 5:05 PM EST
AntonioOmuroM.D..jpg

Article ID: 703369

Antonio Omuro named new Neuro-Oncology Chief at Yale Cancer Center

Yale Cancer Center

Antonio Omuro, M.D., has been appointed the new Chief of Neuro-Oncology and a Leader for the Brain Tumor Program at Yale Cancer Center (YCC) and Smilow Cancer Hospital.

Released:
5-Nov-2018 10:45 AM EST
DanielDiMaioMDPhD.jpg
  • Embargo expired:
    16-Aug-2018 11:00 AM EDT

Article ID: 699077

Discovery May Help Provide Clues for Fighting and Treating HPV

Yale Cancer Center

Yale Cancer Center (YCC) scientists have filled in a key gap in understanding the unusual route by which the Human papillomavirus (HPV) infects cells.

Released:
15-Aug-2018 7:05 PM EDT
  • Embargo expired:
    19-Jul-2018 2:00 PM EDT

Article ID: 697587

Low/No Calorie Soft Drinks Improve Outcomes in Advanced Colon Cancer Patients

Yale Cancer Center

Drinking artificially-sweetened beverages is associated with a significantly lower risk of colon cancer recurrence and cancer death, a team of investigators led by a Yale Cancer Center scientist has found. The study was published today in the journal The Public Library of Science One.

Released:
18-Jul-2018 11:05 AM EDT
Dr.SkylerJohnson.jpg
  • Embargo expired:
    19-Jul-2018 11:00 AM EDT

Article ID: 697589

Replacing Conventional Cancer Treatment with Complementary Medicine Decreases Patient Survival

Yale Cancer Center

People who received complementary therapy for curable cancers were more likely to refuse at least one component of their conventional cancer treatment, and were more likely to die as a result, according to researchers from Yale Cancer Center and the Cancer Outcomes, Public Policy and Effectiveness Research Center (COPPER) at Yale School of Medicine. The findings were reported today online in JAMA Oncology.

Released:
18-Jul-2018 11:05 AM EDT
MichaelGirardiMDPhD.jpg

Article ID: 696523

Five Ways to Lower Your Skin Cancer Risk

Yale Cancer Center

Experts at Yale Cancer Center say unless you take the right precautions, sun exposure (even if you don't get scorched) can damage your skin, causing wrinkles, age spots and even skin cancer.

Released:
22-Jun-2018 10:05 AM EDT

Article ID: 692170

Yale Expert Discusses Treatment for Endometrial Cancer

Yale Cancer Center

Dr. Alesandro Santin Discusses Treatment for Endometrial Cancer

Released:
3-Apr-2018 3:55 PM EDT
ct.jpg

Article ID: 692168

Clinical Trials Take Innovative Approach

Yale Cancer Center

Since their arrivals at Yale within the past six years, Patricia LoRusso (right) and Joseph Paul Eder (center)—shown conferring with Clinical Research Coordinator Alexandra Minnella—have overseen a sharp increase in the number of clinical trials conducted by the Phase I Program at Yale Cancer Center.

Released:
3-Apr-2018 3:55 PM EDT

Showing results

110 of 216

Chat now!